Theresa Operaña

Theresa Operaña, PhD, is an experienced leader in medical affairs and strategic operations, currently serving as Director of Program Management & Strategic Operations at Riva Therapeutics since June 2022. Previously, Theresa held positions such as Director of Global Medical Affairs at Turning Point Therapeutics, where responsibilities included leading global publications and conference planning, and Associate Director of Global Medical Affairs - Scientific Communications at Rakuten Medical, focusing on scientific messaging and training. Theresa's extensive background includes a role as Senior Manager at Intercept Pharmaceuticals and medical affairs scientist at bioTheranostics, where contributions involved scientific outreach, biomarker strategy, and publication planning. Theresa also completed postdoctoral fellowships at the Joslin Diabetes Center and CONNECT, and earned a PhD in Biomedical Sciences from UC San Diego, with research centered on drug metabolism and xenobiotic receptors.